Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review.
Balma M, Liberini V, Racca M, Laudicella R, Bauckneht M, Buschiazzo A, Nicolotti DG, Peano S, Bianchi A, Albano G, Quartuccio N, Abgral R, Morbelli SD, D'Alessandria C, Terreno E, Huellner MW, Papaleo A, Deandreis D. Balma M, et al. Among authors: deandreis d, d alessandria c. Front Med (Lausanne). 2022 Apr 12;9:881551. doi: 10.3389/fmed.2022.881551. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35492341 Free PMC article.
Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10%) well-differentiated endocrine carcinoma staging.
Abgral R, Leboulleux S, Déandreis D, Aupérin A, Lumbroso J, Dromain C, Duvillard P, Elias D, de Baere T, Guigay J, Ducreux M, Schlumberger M, Baudin E. Abgral R, et al. Among authors: deandreis d. J Clin Endocrinol Metab. 2011 Mar;96(3):665-71. doi: 10.1210/jc.2010-2022. Epub 2010 Dec 30. J Clin Endocrinol Metab. 2011. PMID: 21193541
68Ga-DOTA-TOC PET/CT of von Hippel-Lindau Disease.
Liberini V, Nicolotti DG, Maccario M, Finessi M, Deandreis D. Liberini V, et al. Among authors: deandreis d. Clin Nucl Med. 2019 Feb;44(2):125-126. doi: 10.1097/RLU.0000000000002395. Clin Nucl Med. 2019. PMID: 30516678
Impact of functional imaging in prostate cancer: a clinical point of view.
Nicolotti DG, Finessi M, Guarneri A, Pilati E, Giunta F, Deandreis D. Nicolotti DG, et al. Among authors: deandreis d. Q J Nucl Med Mol Imaging. 2019 Mar;63(1):1-6. doi: 10.23736/S1824-4785.19.03160-1. Epub 2019 Jan 15. Q J Nucl Med Mol Imaging. 2019. PMID: 30644307 No abstract available.
68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy.
Deandreis D, Guarneri A, Ceci F, Lillaz B, Bartoncini S, Oderda M, Nicolotti DG, Pilati E, Passera R, Zitella A, Bellò M, Parise R, Carlevato R, Ricardi U, Gontero P. Deandreis D, et al. Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2804-2815. doi: 10.1007/s00259-020-04809-8. Epub 2020 Apr 20. Eur J Nucl Med Mol Imaging. 2020. PMID: 32314028
18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival.
Polverari G, Ceci F, Bertaglia V, Reale ML, Rampado O, Gallio E, Passera R, Liberini V, Scapoli P, Arena V, Racca M, Veltri A, Novello S, Deandreis D. Polverari G, et al. Among authors: deandreis d. Cancers (Basel). 2020 May 5;12(5):1163. doi: 10.3390/cancers12051163. Cancers (Basel). 2020. PMID: 32380754 Free PMC article.
139 results